Page last updated: 2024-12-05

1-naphthoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Naphthoic acid is a white crystalline solid with a melting point of 160-161 °C. It is a carboxyl derivative of naphthalene, and is a common starting material in the synthesis of other naphthalene derivatives. It is a weak acid, with a pKa of 3.69. 1-Naphthoic acid is used in the production of dyes, pharmaceuticals, and other organic compounds. It has been studied for its potential use in the treatment of cancer and other diseases. 1-Naphthoic acid has also been found to be a component of some natural products, such as the resin of the Balsam of Peru tree. The compound is synthesized through a number of methods, including the oxidation of naphthalene, the reaction of naphthalene with carbon monoxide and hydrogen in the presence of a catalyst, and the hydrolysis of 1-naphthyl cyanide. 1-Naphthoic acid is a potent inhibitor of the enzyme farnesyltransferase, which is involved in the synthesis of proteins required for cell growth and division. This property makes it a potential target for the development of new anticancer drugs. Research on 1-naphthoic acid is ongoing, and scientists are continuing to investigate its potential applications in medicine and other fields.'

naphthoic acid : An aromatic carboxylic acid that consists of a naphthalene skeleton substituted by one or more carboxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6847
CHEMBL ID1160
CHEBI ID36466
SCHEMBL ID17258
MeSH IDM0226455

Synonyms (60)

Synonym
CHEBI:36466 ,
nsc-37569
1-carboxynaphthalene
.alpha.-naphthoic acid
nsc37569
alpha-naphthylcarboxylic acid
naphthalene-alpha-carboxylic acid
naphthalene-1-carboxylic acid
einecs 201-681-9
nsc 37569
carboxynaphthalene
naphthalenecarboxylic acid
ai3-16902
naphthoic acid
1-naphthoic acid ,
86-55-5
inchi=1/c11h8o2/c12-11(13)10-7-3-5-8-4-1-2-6-9(8)10/h1-7h,(h,12,13
1-naphthalenecarboxylic acid
1-naphthoic acid, 96%
alpha-naphthoic acid
AC-4952
BMSE000178
CHEMBL1160
FT-0650501
N0024
AKOS000120400
1320-04-3
STL169143
FT-0672610
AE-508/40217755
2niv4o66bh ,
unii-2niv4o66bh
FT-0647744
FS-3492
F3110-2246
CCG-208689
naphthalene carboxylic acid
1-napthoic acid
l-naphthoic acid
naphthalene mono carboxylic acid
1-naphthalene carboxylic acid
1--naphthoic acid
1-naphtoic acid
SCHEMBL17258
1-naphthoic acid [mi]
.alpha.-naphthylcarboxylic acid
1-naphthioic acid
naphthalene-.alpha.-carboxylic acid
Q-200129
1-naphthoicacid
CS-W020013
mfcd00004007
SY005963
DTXSID50861668
Q21050984
BCP27257
AMY25798
AC8079
EN300-20214
HY-Y0236

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" qPCR measurement of CYP1A induction proved different between isomers dosed at respective concentrations affecting 50% of exposed individuals (EC50s)."( Differential developmental toxicity of naphthoic acid isomers in medaka (Oryzias latipes) embryos.
Carney, MW; Erwin, K; Hardman, R; Hinton, DE; Kullman, SW; Volz, DC; Yuen, B, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fungal xenobiotic metaboliteAny fungal metabolite produced by metabolism of a xenobiotic compound in fungi.
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
naphthoic acidAn aromatic carboxylic acid that consists of a naphthalene skeleton substituted by one or more carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID28691log LD50 was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (16.67)18.7374
1990's6 (8.33)18.2507
2000's15 (20.83)29.6817
2010's35 (48.61)24.3611
2020's4 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.45 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index52.27 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other70 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]